Symbol.Subcutaneous implantation of bone marrow mesenchymal stem cells-polyglycolic acid scaffold complex to construct small diameter tissue-engineered blood vessels**☆

  • Gao, Guo-liang
  • Song, Jian-fei
  • Wang, Hai-yong
  • Zheng, Min
  • Wang, Wei
  • Jiang, Yi-yao
  • Du, Zhen-zong
Journal of Clinical Rehabilitative Tissue Engineering Research 15(51):p 9544-9548, December 17, 2011.

Abstract

BACKGROUND:

Our former studies have shown that bone marrow mesenchymal stem cells (BMMSCs) can be induced differentiation to vascular smooth muscle-like cells (VSMLCs) and vascular endothelium-like cells (VELCs), which are compatible with collagen-embedded polyglycolic acid scaffolds.

OBJECTIVE:

To investigate the possibility of constructing small diameter tissue-engineered blood vessels via subcutaneous implantation.

METHODS:

The cells-scaffold complex was produced by separately seeding VSMLCs and VELCs derived from BMMSCs on polyglycolic acid collagen scaffolds. The two layers were separated by ECMgel. The cells-scaffold complex was subcutaneous implanted into small diameter tissue-engineered blood vessels.

RESULTS AND CONCLUSION:

Histological analysis of the small diameter tissue-engineered blood vessel walls revealed a typical artery structure, which was similar to natural vessels. The tissue-engineered blood vessels were not broken down under a force of 26.6 kPa. Eight weeks after implantation, the Brdu-labeled seed cells were found in the three layers of the vessel walls. The results revealed that the subcutaneous tissue was a good bioreactor to construct small diameter tissue-engineered blood vessels.

Copyright © 2011 Publishing House of Neural Regeneration Research